Manipulating Eggs to Avoid Disease

A United Kingdom ethics council approves altering human egg cells, which could allow doctors to correct mitochondrial disease in IVF patients.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA COMMONS, EKEM

Treating the eggs of IVF mothers with mitochondrial disease is ethical as long as the procedure is proven safe, according a report released on Monday (June 11) from the Nuffield Council of Bioethics in the United Kingdom.

Mitochondrial malfunctions that result in deafness and diseases that resemble multiple sclerosis and Parkinson’s arise from defective mitochondrial DNA, which is in part responsible for the organelle’s function and growth. However, since mitochondria are only passed down via the mother, researchers have been experimenting with techniques to transfer a nucleus from the mother’s eggs into a donated cell containing healthy mitochondria, either before or after fertilization. The resulting child would then have genetic material both from the mother and the donor, raising ethical questions.

The Nuffield council said ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Edyta Zielinska

    This person does not yet have a bio.
Share
TS Digest January 2025
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
New Approaches for Decoding Cancer at the Single-Cell Level

New Approaches for Decoding Cancer at the Single-Cell Level

Biotium logo
Learn How 3D Cell Cultures Advance Tissue Regeneration

Organoids as a Tool for Tissue Regeneration Research 

Acro 

Products

Artificial Inc. Logo

Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo

Sapient Logo

Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators

Bio-Rad Logo

Bio-Rad Extends Range of Vericheck ddPCR Empty-Full Capsid Kits to Optimize AAV Vector Characterization

Scientist holding a blood sample tube labeled Mycoplasma test in front of many other tubes containing patient samples

Accelerating Mycoplasma Testing for Targeted Therapy Development